David Mckinley Sells 8,321 Shares of Henry Schein, Inc. (HSIC) Stock

Henry Schein, Inc. (NASDAQ:HSIC) insider David Mckinley sold 8,321 shares of the stock in a transaction dated Friday, November 30th. The stock was sold at an average price of $88.77, for a total transaction of $738,655.17. Following the transaction, the insider now owns 68,012 shares in the company, valued at $6,037,425.24. The sale was disclosed in a filing with the SEC, which is available through this link.

Shares of NASDAQ:HSIC traded up $1.20 during trading on Monday, reaching $90.40. The stock had a trading volume of 1,296,400 shares, compared to its average volume of 1,555,970. Henry Schein, Inc. has a one year low of $62.56 and a one year high of $90.69. The stock has a market capitalization of $13.60 billion, a P/E ratio of 25.11, a P/E/G ratio of 2.94 and a beta of 0.89. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.70 and a current ratio of 1.30.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 6th. The company reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.02. Henry Schein had a net margin of 3.00% and a return on equity of 20.40%. The business had revenue of $3.28 billion for the quarter, compared to analysts’ expectations of $3.37 billion. During the same period last year, the business earned $0.87 EPS. The company’s revenue was up 3.8% compared to the same quarter last year. On average, research analysts forecast that Henry Schein, Inc. will post 4.12 EPS for the current year.

HSIC has been the topic of several recent research reports. Goldman Sachs Group reiterated a “neutral” rating on shares of Henry Schein in a report on Friday, October 19th. Morgan Stanley increased their target price on shares of Henry Schein from $65.00 to $66.00 and gave the stock an “underweight” rating in a report on Tuesday, October 9th. BidaskClub cut shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 23rd. ValuEngine upgraded shares of Henry Schein from a “strong sell” rating to a “sell” rating in a report on Thursday, September 13th. Finally, Leerink Swann set a $100.00 price target on shares of Henry Schein and gave the company a “buy” rating in a report on Tuesday, August 7th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $86.47.

Institutional investors have recently made changes to their positions in the stock. McAdam LLC purchased a new position in shares of Henry Schein in the 3rd quarter valued at approximately $104,000. NEXT Financial Group Inc purchased a new position in shares of Henry Schein in the 3rd quarter valued at approximately $103,000. Piedmont Investment Advisors LLC purchased a new position in shares of Henry Schein in the 2nd quarter valued at approximately $130,000. Whitener Capital Management Inc. purchased a new position in shares of Henry Schein in the 3rd quarter valued at approximately $160,000. Finally, Fuller & Thaler Asset Management Inc. raised its position in shares of Henry Schein by 57.1% in the 2nd quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock valued at $160,000 after purchasing an additional 800 shares during the last quarter.

ILLEGAL ACTIVITY NOTICE: “David Mckinley Sells 8,321 Shares of Henry Schein, Inc. (HSIC) Stock” was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of US & international copyright laws. The legal version of this article can be viewed at https://www.com-unik.info/2018/12/03/david-mckinley-sells-8321-shares-of-henry-schein-inc-hsic-stock.html.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Article: Cost of Equity For A Business, Investors

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit